Effects of the MDM2 promoter SNP285 and SNP309 on Sp1 transcription factor binding and cancer risk.
about
Association of the MDM2 SNP285 Polymorphism with Cancer Susceptibility: A Meta-AnalysisAssociation between murine double minute 2 T309G polymorphism and risk of liver cancer.MDM2 SNP309 promoter polymorphism and p53 mutations in urinary bladder carcinoma stage T1.Esculetin, a Coumarin Derivative, Exhibits Anti-proliferative and Pro-apoptotic Activity in G361 Human Malignant Melanoma.Murine Double-Minute 2 Homolog Single Nucleotide Polymorphisms 285 and 309 in Cervical Carcinogenesis.Functional role of post-translational modifications of Sp1 in tumorigenesisTargeting polo-like kinase 1, a regulator of p53, in the treatment of adrenocortical carcinoma.Murine Double Minute 2 SNP T309G Polymorphism and Urinary Tract Cancer Risk: A Meta-AnalysisMDM2 and P53 polymorphisms contribute together to the risk and survival of prostate cancerHomozygous G/G variant of SNP309 in the human MDM2 gene is associated with earlier tumor onset in Caucasian female renal cell carcinoma patients.Age at cancer onset in germline TP53 mutation carriers: association with polymorphisms in predicted G-quadruplex structures.MDM2's social network.Sp1 and the 'hallmarks of cancer'.Anti-proliferative properties of kahweol in oral squamous cancer through the regulation specificity protein 1.Association between MDM2-SNP309 and p53R72P polymorphisms and the risk of bladder cancer in the Mongolian population.Polymorphisms in the MDM2 gene and risk of malignant bone tumors: a meta-analysis.The MDM2 polymorphism SNP309 is associated with clinical characteristics and outcome in diffuse large B-cell lymphoma.Surface Plasmon Resonance Sensing of Biorecognition Interactions within the Tumor Suppressor p53 Network.Quantitative assessment of the association between HDMX polymorphism and sarcoma.Evaluation of TP53 Pro72Arg and MDM2 SNP285-SNP309 polymorphisms in an Italian cohort of LFS suggestive patients lacking identifiable TP53 germline mutations.Effects of MDM2 promoter polymorphisms on the development of cervical neoplasia in a Southeastern Brazilian population.
P2860
Q28066326-E2C5DA68-CB54-4E81-881E-5F6FD78411DCQ34433411-F533C0C4-C55E-450C-9F23-60922C178949Q34565346-09180AC2-98BC-493E-BC7F-5DB543EA08B5Q35820967-834FC7BD-5F93-490D-B70E-38BA0E0C93EAQ35930829-D2C43521-FFBC-474B-A3F6-4005F300386EQ36416763-24E7DA17-C9E4-4B7D-B8BF-6941B5664115Q36452688-586E7668-D0CA-463C-8CCB-1F57B1BC7416Q37205283-3E45A4BA-66F4-4589-896F-CE6DEA69400FQ37362527-536D3A41-D750-4454-8025-E47725A8E259Q37499251-1C3CA561-51B6-467E-981B-887990BAFBDCQ37687337-3F2E88E1-0FD9-495F-954B-FC8943FC08EFQ38149734-8497BBAD-3C46-4F4C-9897-624E33FDF8AFQ38267908-8B97477A-EAE7-4D02-BC09-C918FDF6E2DAQ38958948-3F47487B-6C65-4601-9549-2730101DC39FQ41145939-FC1285EB-E055-41AF-A0F6-264EB413B21DQ44820188-1BFD314F-24BA-442A-9D5D-3C1AD72185DCQ45228677-D6039FA3-0247-45C0-8BC7-EDD31D66D748Q47109687-C3DC29A3-DE9A-4D02-80AD-B72E6EE47676Q53147977-8641E948-6A54-41F1-B8C5-DB139B776D49Q53727895-310F4736-38DC-4312-9967-5CC858D6021AQ54190110-36761950-9A2B-446C-82E4-58AE60CA4608
P2860
Effects of the MDM2 promoter SNP285 and SNP309 on Sp1 transcription factor binding and cancer risk.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Effects of the MDM2 promoter S ...... actor binding and cancer risk.
@ast
Effects of the MDM2 promoter S ...... actor binding and cancer risk.
@en
type
label
Effects of the MDM2 promoter S ...... actor binding and cancer risk.
@ast
Effects of the MDM2 promoter S ...... actor binding and cancer risk.
@en
prefLabel
Effects of the MDM2 promoter S ...... actor binding and cancer risk.
@ast
Effects of the MDM2 promoter S ...... actor binding and cancer risk.
@en
P2860
P356
P1433
P1476
Effects of the MDM2 promoter S ...... actor binding and cancer risk.
@en
P2860
P304
P356
10.4161/TRNS.2.5.16813
P577
2011-09-01T00:00:00Z